Johnson & Johnson

Johnson & Johnson was formed in 1886 and is a pharmaceutical, medical device, and consumer packaged goods firm. This American multinational corporation, located in New Brunswick, New Jersey, employs around 132,000 people as of 2020. It operates in over 60 countries and has over 250 subsidiaries.

Since 2012, Johnson & Johnson has been the most profitable of the big biotech companies. The company achieved $82.059 billion in revenue in 2019. On April 14, 2020, Johnson & Johnson reported first-quarter sales of $20.7 billion, up 3.3 percent from the previous year. In the second and third quarters of 2020, the company made $18.3 billion and $21.1 billion, respectively. COVID-19's impact was evident in a 10.8% decline in revenue in the second quarter. The company's 1.7 percent gain in the third-quarter financial report for 2020 reflects the strength of Johnson & Johnson's business model, the quality and breadth of its portfolio, and the company's constant commitment to innovation. In the first, second, and third quarters of 2020, Johnson & Johnson produced $60.1 billion in revenue.

Because of the combination of current technology and their experience, incredible things are possible. J&J's consumer business is working on digital solutions to help customers track the condition of their skin. Pharmaceutical researchers are utilizing AI to design life-saving drugs, while medical device engineers are 3D printing prosthetic joints that are personalized for each patient. Consider what the rest of their 134,000-strong workforce is accomplishing across 260 companies in more than 60 countries. They are redefining what it means to be a significant business in today's world.

Founded: 1886
Headquarters: New Brunswick, NJ
Market Cap: $498.44B AUD ($368.91B USD)
Website: https://www.jnj.com/